Patents by Inventor Robert Eferl

Robert Eferl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transgenic animal as a model for fibrotic diseases
    Patent number: 7807864
    Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: October 5, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Erwin Wagner, Robert Eferl
  • Transgenic Animal as a Model for Fibrotic Diseases
    Publication number: 20060195916
    Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.
    Type: Application
    Filed: February 21, 2006
    Publication date: August 31, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Erwin Wagner, Robert Eferl